Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly
Clinical trial NCT04803513 · UNKNOWN
Trial details
- NCT number
- NCT04803513
- Sponsor
- Campus Bio-Medico University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-01
- Primary completion
- 2022-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.